Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting

Jouko Levijoki; Lasse Saloranta; Johanna Tuunainen; Janne Kaskinoro; Sari Pappinen; Sandra Nourry; Anne-Marie Betat; Anne Maurin; Maarit Pakarinen; Sari Häkkinen; Johanna Tervapuro; Hertta Pihlasvaara; Christophe Drieu La Rochelle; Heikki Joensuu

doi:10.1124/jpet.122.001444

OtherChemotherapy, Antibiotics, and Gene Therapy

Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting

Jouko Levijoki, Lasse Saloranta, Johanna Tuunainen, Janne Kaskinoro, Sari Pappinen, Sandra Nourry, Anne-Marie Betat, Anne Maurin, Maarit Pakarinen, Sari Häkkinen, Johanna Tervapuro, Hertta Pihlasvaara, Christophe Drieu La Rochelle and Heikki Joensuu

Journal of Pharmacology and Experimental Therapeutics January 12, 2023, JPET-AR-2022-001444; DOI: https://doi.org/10.1124/jpet.122.001444

Jouko Levijoki

1Oncology Research, Orion Corporation, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jouko Levijoki
For correspondence: jouko.levijoki@orionpharma.com

Lasse Saloranta

2Animal Welfare & AH Microbiome, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johanna Tuunainen

3Translational PK/PD, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Janne Kaskinoro

4Antibody Drug Conjugates, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sari Pappinen

5Biopharmaceutics and Chemical Analytic, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandra Nourry

6Pharmacology, Biotrial, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne-Marie Betat

6Pharmacology, Biotrial, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne Maurin

6Pharmacology, Biotrial, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maarit Pakarinen

7Translational Bioanalytics & Biomarkers, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sari Häkkinen

7Translational Bioanalytics & Biomarkers, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johanna Tervapuro

8Formulation Development and CTS, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hertta Pihlasvaara

9Structural Biology and Analytics, Orion Corporation Orion Pharma, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christophe Drieu La Rochelle

6Pharmacology, Biotrial, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Heikki Joensuu

10Department of Oncology, Orion Corporation Orion Pharma and Helsinki University Hospital and University of Helsinki, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 384, Issue 2

1 Feb 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherChemotherapy, Antibiotics, and Gene Therapy